U.S., Oct. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07852832) titled 'Effects of Psilocybin on Craving in Nicotine Dependence' on Sept. 11.
Brief Summary: This pilot study will examine how a single 25 mg dose of psilocybin affects nicotine craving in people with nicotine dependence. Following psilocybin administration, participants will complete repeated brain imaging (MRI) sessions that mimic the design and procedures of the SCANS (H24-02776) study they previously completed. This will allow us to compare craving and related brain activity before and after psilocybin. We will also explore changes in nicotine use, thoughts about nicotine, motivation to quit, and mental health symptoms. Findings will hel...